Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Other Non-Current Liabilities (2020 - 2025)

Historic Other Non-Current Liabilities for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $4.3 million.

  • GeneDx Holdings' Other Non-Current Liabilities fell 6855.24% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 6855.24%. This contributed to the annual value of $5.5 million for FY2024, which is 6254.5% down from last year.
  • According to the latest figures from Q3 2025, GeneDx Holdings' Other Non-Current Liabilities is $4.3 million, which was down 6855.24% from $3.3 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Other Non-Current Liabilities ranged from a high of $61.4 million in Q3 2021 and a low of $3.3 million during Q2 2025
  • In the last 5 years, GeneDx Holdings' Other Non-Current Liabilities had a median value of $20.2 million in 2022 and averaged $18.1 million.
  • Examining YoY changes over the last 5 years, GeneDx Holdings' Other Non-Current Liabilities showed a top increase of 95626.81% in 2021 and a maximum decrease of 8550.78% in 2021.
  • Over the past 5 years, GeneDx Holdings' Other Non-Current Liabilities (Quarter) stood at $21.9 million in 2021, then increased by 9.64% to $24.0 million in 2022, then plummeted by 38.65% to $14.7 million in 2023, then plummeted by 62.54% to $5.5 million in 2024, then decreased by 22.85% to $4.3 million in 2025.
  • Its Other Non-Current Liabilities was $4.3 million in Q3 2025, compared to $3.3 million in Q2 2025 and $6.6 million in Q1 2025.